Horizon Kinetics’s AstraZeneca AZN Stock Holding History

Horizon Kinetics’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$959K	Hold	12,632	–	–	0.03%	165
2018 Q3	$1M	Sell	12,632 -1,000	-7%	-$75.6K	0.02%	183
2018 Q2	$957K	Sell	13,632 -1,610	-11%	-$116K	0.02%	182
2018 Q1	$1.07M	Sell	15,242 -300	-2%	-$20.8K	0.03%	171
2017 Q4	$1.08M	Sell	15,542 -81	-0.5%	-$5.46K	0.03%	174
2017 Q3	$1.06M	Buy	15,623 +1,354	+9%	+$85.5K	0.03%	182
2017 Q2	$973K	Buy	14,269 +118	+0.8%	+$7.71K	0.03%	198
2017 Q1	$881K	Hold	14,151	–	–	0.03%	209
2016 Q4	$773K	Hold	14,151	–	–	0.03%	223
2016 Q3	$930K	Hold	14,151	–	–	0.03%	207
2016 Q2	$854K	Hold	14,151	–	–	0.02%	226
2016 Q1	$797K	Buy	14,151 +151	+1%	+$9.07K	0.02%	234
2015 Q4	$951K	Hold	14,000	–	–	0.02%	207
2015 Q3	$891K	Sell	14,000 -12,000	-46%	-$789K	0.02%	208
2015 Q2	$828K	Buy	26,000 +13,000	+100%	+$890K	0.01%	359
2015 Q1	$890K	Hold	13,000	–	–	0.01%	258
2014 Q4	$915K	Hold	13,000	–	–	0.01%	253
2014 Q3	$929K	Hold	13,000	–	–	0.01%	243
2014 Q2	$966K	Sell	13,000 -106	-0.8%	-$7.66K	0.01%	253
2014 Q1	$850K	Buy	13,106 +1,086	+9%	+$70.1K	0.01%	271
2013 Q4	$714K	Hold	12,020	–	–	0.01%	285
2013 Q3	$624K	Buy	12,020 +20	+0.2%	+$1K	0.01%	290
2013 Q2	$568K	Buy	+12,000	New	+$611K	0.01%	307

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Horizon Kinetics's AZN Position: Q4 2018 in Review

Horizon Kinetics held its AstraZeneca (AZN) position steady in Q4 2018 at 12,632 shares worth $959K. The position accounts for 0.03% of the portfolio, ranked #165.

Horizon Kinetics first reported a position in AZN in Q2 2013 and has held it in 23 quarters since. The position peaked at $1.08M in Q4 2017. 557 funds tracked by Wall St. Rank hold AZN as of Q4 2018.

Horizon Kinetics held 12,632 shares of AstraZeneca worth $959K as of Q4 2018.
Horizon Kinetics left its AstraZeneca share count unchanged in Q4 2018.
AstraZeneca made up 0.03% of Horizon Kinetics's portfolio in Q4 2018, its #165 holding.
Horizon Kinetics first reported a position in AstraZeneca in Q2 2013 and has held it in 23 quarters since.
Horizon Kinetics's AstraZeneca position peaked at $1.08M in Q4 2017.
557 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2018.

Based on Horizon Kinetics's 13F filing for Q4 2018, filed 14 Feb 2019.